Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0000899243-23-016076

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PERCEPTIVE ADVISORS LLC Director 2023-06-15 Grant or award · Stock Option (Right to Buy) +45,000 45,000 I
Loading xslF345X04/doc4.xml…